Factors Affecting Tamoxifen Metabolism in Patients With Breast Cancer: Preliminary Results of the French PHACS Study

Clinical Pharmacology and Therapeutics
Alicja PuszkielFabienne Thomas

Abstract

In addition to the effect of cytochrome P450 (CYP) 2D6 genetic polymorphisms, the metabolism of tamoxifen may be impacted by other factors with possible consequences on therapeutic outcome (efficacy and toxicity). This analysis focused on the pharmacokinetic (PK)-pharmacogenetic evaluation of tamoxifen in 730 patients with adjuvant breast cancer included in a prospective multicenter study. Plasma concentrations of tamoxifen and six major metabolites, the genotype for 63 single-nucleotide polymorphisms, and comedications were obtained 6 months after treatment initiation. Plasma concentrations of endoxifen were significantly associated with CYP2D6 diplotype (P < 0.0001), CYP3A4*22 genotype (P = 0.0003), and concomitant intake of potent CYP2D6 inhibitors (P < 0.001). Comparison of endoxifen levels showed that the CYP2D6 phenotype classification could be improved by grouping intermediate metabolizer (IM)/IM and IM/poor metabolizer diplotype into IM phenotype for future use in tamoxifen therapy optimization. Finally, the multivariable regression analysis showed that formation of tamoxifen metabolites was independently impacted by CYP2D6 diplotype and CYP3A4*22, CYP2C19*2, and CYP2B6*6 genetic polymorphisms.

References

Nov 19, 2004·Cancer Research·Charnita Zeigler-JohnsonTimothy R Rebbeck
Nov 1, 2007·Clinical Pharmacology and Therapeutics·A GaedigkJ S Leeder
Oct 8, 2009·JAMA : the Journal of the American Medical Association·Werner SchrothHiltrud Brauch
Mar 25, 2011·Clinical Pharmacology and Therapeutics·L MadlenskyJ P Pierce
Apr 13, 2011·British Journal of Clinical Pharmacology·Joanne S L LimBalram Chowbay
Mar 8, 2012·Journal of the National Cancer Institute·James M RaeUNKNOWN ATAC trialists
Mar 8, 2012·Journal of the National Cancer Institute·Meredith M ReganUNKNOWN Breast International Group (BIG) 1-98 Collaborative Group
Jan 25, 2014·Clinical Pharmacology and Therapeutics·K R CrewsUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Sep 1, 2014·Journal of Pharmaceutical and Biomedical Analysis·Cécile ArellanoEtienne Chatelut
Apr 9, 2015·Therapeutic Drug Monitoring·Marina V AntunesGilberto Schwartsmann
Apr 25, 2015·British Journal of Clinical Pharmacology·Daniel L HertzWilliam J Irvin
May 15, 2015·Clinical Pharmacology and Therapeutics·J K HicksUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Oct 9, 2015·Clinical Pharmacokinetics·Lisette BinkhorstRon H J Mathijssen
Dec 23, 2016·Breast Cancer Research and Treatment·A H M de Vries SchultinkJ H Beijnen
Aug 30, 2017·European Journal of Clinical Pharmacology·A B Sanchez SpitmanH J Guchelaar
Feb 1, 2018·Clinical Pharmacology and Therapeutics·Matthew P GoetzTeri E Klein
Feb 21, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Patrick NevenHenk-Jan Guchelaar
Jan 25, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anabel Sanchez-SpitmanHenk-Jan Guchelaar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pharmacogenomics and Personalized Medicine
Ekaphop SirachainanChonlaphat Sukasem
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Hiltrud Brauch, V Craig Jordan
© 2022 Meta ULC. All rights reserved